EcoDrugPlus

Glutamate Receptor 4

Ensembl ID : ENSHCOG00000009872
Gene Symbol: LOC109515646
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSHCOG00000002688
Gene Symbol: LOC109521645
3 Cross references
205 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSHCOG00000008642
Gene Symbol: LOC109509255
2 Cross references
132 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSHCOG00000010966
Gene Symbol: LOC109511254
2 Cross references
98 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSHCOG00000020495
Gene Symbol: LOC109515406
2 Cross references
212 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSHCOG00000008581
Gene Symbol: LOC109520196
3 Cross references
230 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSHCOG00000009979
Gene Symbol: LOC109517580
2 Cross references
232 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSHCOG00000000150
Gene Symbol: GSK3B
3 Cross references
176 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSHCOG00000006072
Gene Symbol: LOC109518393
3 Cross references
188 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSHCOG00000011920
Gene Symbol: LOC109531651
3 Cross references
186 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSHCOG00000011689
Gene Symbol: LOC109512145
2 Cross references
155 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSHCOG00000005629
Gene Symbol: LOC109513138
3 Cross references
135 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).